ATE539152T1 - Neue verfahren - Google Patents

Neue verfahren

Info

Publication number
ATE539152T1
ATE539152T1 AT06760292T AT06760292T ATE539152T1 AT E539152 T1 ATE539152 T1 AT E539152T1 AT 06760292 T AT06760292 T AT 06760292T AT 06760292 T AT06760292 T AT 06760292T AT E539152 T1 ATE539152 T1 AT E539152T1
Authority
AT
Austria
Prior art keywords
new procedures
proteins
protein
domain
expression
Prior art date
Application number
AT06760292T
Other languages
English (en)
Inventor
Kyung Johanson
John Trill
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Application granted granted Critical
Publication of ATE539152T1 publication Critical patent/ATE539152T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT06760292T 2005-05-20 2006-05-19 Neue verfahren ATE539152T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68325405P 2005-05-20 2005-05-20
PCT/US2006/019872 WO2006127682A2 (en) 2005-05-20 2006-05-19 Novel methods

Publications (1)

Publication Number Publication Date
ATE539152T1 true ATE539152T1 (de) 2012-01-15

Family

ID=37452729

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06760292T ATE539152T1 (de) 2005-05-20 2006-05-19 Neue verfahren

Country Status (6)

Country Link
US (1) US8221998B2 (de)
EP (1) EP1885867B1 (de)
JP (1) JP5249751B2 (de)
AT (1) ATE539152T1 (de)
ES (1) ES2379096T3 (de)
WO (1) WO2006127682A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5040438B2 (ja) * 2007-05-21 2012-10-03 Ｊｎｃ株式会社 Ｆｃ結合ドメインとカルシウム結合発光蛋白質との融合蛋白質、それをコードする遺伝子およびそれらの用途
TW201029662A (en) 2008-12-19 2010-08-16 Glaxo Group Ltd Novel antigen binding proteins
TW201210612A (en) 2010-06-03 2012-03-16 Glaxo Group Ltd Humanised antigen binding proteins
KR102813535B1 (ko) * 2021-11-09 2025-05-26 포항공과대학교 산학협력단 식물에서 재조합 단백질 발현의 증진에 있어서 gb1 도메인 융합의 효과

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9201331D0 (sv) * 1992-04-28 1992-04-28 Hightech Receptor C O Active Protein l och hybridproteiner daerav
US6663862B1 (en) * 1999-06-04 2003-12-16 Duke University Reagents for detection and purification of antibody fragments
GB0017720D0 (en) * 2000-07-19 2000-09-06 Got A Gene Ab Modified virus
WO2003100022A2 (en) * 2002-05-24 2003-12-04 Restoragen, Inc. Methods and dna constructs for high yield production of polypeptides
CA2463301A1 (en) * 2004-04-22 2005-10-22 Atanas Iliev Lalev Method for detecting protein interactions - affinity purification with switching the ligand

Also Published As

Publication number Publication date
WO2006127682A2 (en) 2006-11-30
EP1885867A4 (de) 2009-01-14
US20090148892A1 (en) 2009-06-11
ES2379096T3 (es) 2012-04-20
EP1885867A2 (de) 2008-02-13
JP5249751B2 (ja) 2013-07-31
EP1885867B1 (de) 2011-12-28
US8221998B2 (en) 2012-07-17
WO2006127682A3 (en) 2007-03-01
JP2008539798A (ja) 2008-11-20

Similar Documents

Publication Publication Date Title
MX2018005512A (es) Agentes de union de esclerostina.
CL2011002129A1 (es) Proteinas de union a il-17; construccion de proteina de union a il-17 que comprende un polipeptido ligador o un dominio constante de una inmunoglobulina; conjugado de proteina de union a il-17; vector y celula huesped; composicion para la liberacion de una proteina de union; metodo para reducir la actividad de la il-17.
SG10201405377XA (en) Compositions and methods for antibodies targeting complement protein c5
CY1120413T1 (el) Ειδικα εξανθρωπισμενα αντισωματα στην πρωτοϊνιδιακη μορφη του βητα-αμυλοειδους πεπτιδιου
EA201001223A1 (ru) Стабилизированные белковые композиции
EA201171494A1 (ru) Миметики белка smac
MY174493A (en) Binding agents
EP2507267A4 (de) Zusammensetzungen und verfahren zur erhöhung der serumshaltbarkeit von fc-fusionsproteinen
GT201200189A (es) Antagonistas de pcsk9
EA201270553A1 (ru) Ингибиторы тирозинкиназы брутона
MX2009006594A (es) Formulaciones de ph regulado y estables que contienen polipeptidos.
CY1113199T1 (el) Σταθεροποιημενες συνθεσεις γλυκοσερεμπροσιδασης
EA201791134A1 (ru) Полипептиды химерного фактора viii и их применение
EA201391632A1 (ru) Аминокислотные последовательности, направленные против il-17a, il-17f и/или il-17a/f, и содержащие их полипептиды
WO2011047087A3 (en) Protein detection via nanoreporters
MX2020001497A (es) Sintesis de gamma-carbolinas fusionadas con heterociclo substituido.
ES2674567T3 (es) Proteínas de fusión biespecíficas
WO2009123764A3 (en) Compositions and use of epas1 inhibitors
CL2011000010A1 (es) Anticuerpo monoclonal anti-peptido beta-amiloide; polinucleotido que lo codifica; hibridoma; metodo de produccion; composicion que lo comprende; uso para tratar enfermedades relacionadas con proteinas amiloides; metodo de diagnostico de las mismas; y kit que lo comprende.
CA2705357C (en) Formulations for taci-immunoglobulin fusion proteins
MX2009012358A (es) Agentes de formacion de imagenes opticas.
EA201071221A1 (ru) Гетероциклические соединения
CL2011002994A1 (es) Construccion de proteina que comprende polipeptido casb7439; composicion inmunogenica que comprende dicha construccion; uso de la composicion porque sirve para inducir respuesta inmunitaria al casb7439 en un animal.
MX373170B (es) Variantes de la familia il-1.
ATE539152T1 (de) Neue verfahren